April 7, 2015                                                                                                                              

To our Partners, Friends and Shareholders: Happy Holday. 

We have received additional comments to our trial submission from the FDA. We are currently addressing the comments raised by the FDA and preparing for re-submission soon. Our trial protocol is well refined and we are waiting to be approved in order to start the trial. 

In parallel, we are preparing for the CE inspection. We have finalized all required testing and documentation for it and we anticipate the inspection to take place during second quarter; hopefully soon after to be approved for renewal of our CE mark..

We have edited the testimonial treatments that were presented in a physician conference in Argentina November 2014. You can view the doctors’ satisfaction from the device on the testimonial section of our web site and on YouTube.here and here

During March, we have conducted few presentation meetings with brokers and investors in the USA, in order to introduce our company, our product and our business strategy. We gave group presentations in Florida and New York. Interest was high and we are currently following up and keeping contact through our investor relation program headed by Redington Inc., in the USA.

  

We filed our application for “Israel Health Basket” to NLHS (National List of Health Services). Assessment Division in the Ministry of Health. This, in order to be eligible for national health insurance coverage approval in Israel.  The approving committee is going to conduct its discussion during 2015 and we hope to be approve for the 2016 Israel health basket.

We are conducting initial discussions with potential distributors in Europe, South America and Israel. We hope to have at least one in place before 2015 yearend. As part of it we are preparing for additional Clinical Pilot Trials that will take place in those territories.

We are currently in the process of manufacturing pilot batch of the E-QUER BST devices, in Israel, using outsourced approved production facilities. This, in order to refine our production capabilities and be ready for commercial production of the BST device.

We are currently in the process of manufacturing pilot batch of the E-QUER BST devices, in Israel, using outsourced approved production facilities. This, in order to refine our production capabilities and be ready for commercial production of the BST device.

As we indicated in the past, we are going to file to the SEC a Sub-S document to release additional batch of our investors’ shares for trading. Please continue to look us up under our symbol EQUR.

Our investor relation firm prepared an effective short “At a glance” document on our company to be presented to potential brokers and investors. In is attached for your review. Enjoy. 

All our previous newsletters and announcements can be found also on our web site www.e-qure.com